Gefurulimab—The First Effective Nanobody in Myasthenia Gravis Therapy

Study limitation reported by the research below: “The impact flag 'practice changing' is tentatively applied based on the framing of gefurulimab as the 'first effective nanobody' in MG; this should be confirmed once full paper content is reviewed.”